Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Xytronyx's immunotherapy shows positive preclinical results

April 24, 1997

Triptorelin + melatonin for prostate cancer

April 23, 1997

Antiangiogenic effects of flavopiridol

April 23, 1997

EntreMed produces recombinant Angiostatin

April 22, 1997

ProScript licenses cell cycle regulation technology from Harvard Medical School

April 22, 1997

ImmunoGen's novel anticancer agent eradicates a human cancer in mice

April 22, 1997

Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor

April 22, 1997

Princeton and Lilly disclose nonclassical antifolates

April 22, 1997

Alfacell elucidates action of Onconase

April 22, 1997

PLC-inhibitory peptides from Kyowa Hakko

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...